Dilate
Tropicamide → (14 brands)
5 ml drop
৳ 76.00
Incepta Pharmaceuticals Ltd.
Drug Class
Mydriatic and Cycloplegic agents
Indication
Uveitis
Dosage Form
Ophthalmic Solution
Manufacturer
Incepta Pharmaceuticals Ltd.
Compare Alternate Brands
Same generic (Tropicamide), 1%, Ophthalmic Solution — 8 alternate brands available.
Eyetrop
Apex Pharmaceuticals Ltd.
৳ 80.00
5 ml drop
Mydrimide
Reman Drug Laboratories Ltd.
৳ 85.23
5 ml drop
Tropicam
Aristopharma Ltd.
৳ 85.00
5 ml drop
Tropicamide
Opso Saline Ltd.
৳ 85.29
5 ml drop
Tropicamin
Nipa Pharmaceuticals Ltd.
৳ 85.01
5 ml drop
Tropidil
Popular Pharmaceuticals Ltd.
৳ 85.32
5 ml drop
Indication DetailsView
For mydriasis and cycloplegia for diagnostic procedure, for the treatment of acute and subacute iridocyclitis, chronic iridocyclitis, Adhesions and disruptions of iris and ciliary body, Sclera and iris operations
Therapeutic ClassView
Mydriatic and Cycloplegic agents
PharmacologyView
Tropicamide binds to and blocks the receptors in the muscles of the eye (muscarinic receptor M4). Tropicamide acts by blocking the responses of the iris sphincter muscle to the iris and ciliary muscles to cholinergic stimulation, producing dilation of the pupil and paralysis of the ciliary muscle.
DosageView
For refraction: Instill one or two drops of 1% solution in the eye(s), repeated in five minutes. If patient is not seen within 20 to 30 minutes, an additional drop may be instilled to prolong mydriatic effect.
For examination of fundus: Instill one or two drops of 0.5% solution 15 to 20 minutes prior to examination. Individuals with heavily pigmented irides may require higher strength or more doses.
For examination of fundus: Instill one or two drops of 0.5% solution 15 to 20 minutes prior to examination. Individuals with heavily pigmented irides may require higher strength or more doses.
Side EffectsView
Transient stinging, blurred vision, photophobia and superficial punctate keratitis have been reported with the use of tropicamide. Increased intraocular pressure has been reported following the use of mydriatics. Dryness of the mouth, tachycardia, headache, allergic reactions, nausea, vomiting, pallor, central nervous system disturbances and muscle rigidity have been reported with the use of tropicamide.
ContraindicationsView
Contraindicated in persons showing hypersensitivity to any component of this preparation.
PrecautionsView
The lacrimal sac should be compressed by digital pressure for 2-3 minutes after instillation to avoid excessive systemic absorption.
InteractionsView
Tropicamide may interfere with the antihypertensive action of carbachol, pilocarpine, or ophthalmic cholinesterase inhibitors.
Pregnancy & LactationView
Pregnancy Category C. Tropicamide should be given to a pregnant woman only if clearly needed. It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when tropicamide is administered to a nursing woman.
Storage ConditionsView
Store at 15° to 25°C . Do not refrigerate or store at high temperatures. Keep container tightly closed.